Editorials Regulation and governance of clinical research in the UK BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d238 (Published 13 January 2011) Cite this as: BMJ 2011;342:d238 Article Related content Metrics Responses Peer review Related articles Editor's Choice Institutional and editorial misconduct in the MMR scare Published: 19 January 2011; BMJ 342 doi:10.1136/bmj.d378 News Doctors and industry call on NHS to sustain medicines research Published: 09 February 2011; BMJ 342 doi:10.1136/bmj.d896 News NHS Confederation calls for action to halt loss of clinical trials from UK Published: 09 June 2011; BMJ 342 doi:10.1136/bmj.d3665 Letter Limits of anonymisation in NHS data systems Published: 22 February 2011; BMJ 342 doi:10.1136/bmj.d973 See more Trump chooses Obamacare opponent to lead Health and Human Services BMJ November 30, 2016, 355 i6469; DOI: https://doi.org/10.1136/bmj.i6469 Drug firms need to tackle affordability BMJ November 14, 2016, 355 i6096; DOI: https://doi.org/10.1136/bmj.i6096 World Medical Association’s tainted president, Ketan Desai BMJ November 10, 2016, 355 i5867; DOI: https://doi.org/10.1136/bmj.i5867 Cancer drugs, survival, and ethics BMJ November 09, 2016, 355 i5792; DOI: https://doi.org/10.1136/bmj.i5792 WHO refers $29m Oxford research project to GMC for misconduct BMJ November 07, 2016, 355 i5971; DOI: https://doi.org/10.1136/bmj.i5971 Cited by... Lessons to be learnt from unsuccessful clinical trialsFulltext PDF Limits of anonymisation in NHS data systemsFulltext PDF
